FibroBiologicsFBLG +11.79%13 FCF Yield % is -364.82 as of Jun. 27, 2026. GuruFocus rates FBLG with a GF Score™ of 13/100. The stock has 3 warning signs investors should review. Among 1,418 Biotechnology companies, FibroBiologics ranks worse than 97.46% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
FibroBiologics FCF Yield % Related Terms
FibroBiologics FCF Yield % Historical Data
* Premium members only.
The historical data trend for FibroBiologics's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, FibroBiologics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
FibroBiologics FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, FibroBiologics's FCF Yield % distribution charts can be found below:
* The bar in red indicates where FibroBiologics's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FibroBiologics (FBLG) has a FCF Yield % of -364.82 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on FibroBiologics and its competitors. According to the industry distribution chart, FibroBiologics ranks #1382 out of 1418 companies in the Biotechnology industry, placing it in the top 97.5%.
Is FibroBiologics' FCF Yield % too high?
FibroBiologics' current FCF Yield % is -364.82. Based on the distribution chart, FibroBiologics ranks #1382 out of 1418 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, FibroBiologics has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does FibroBiologics' FCF Yield % compare to BGMS and AIM?
According to the Biotechnology industry distribution chart, FibroBiologics ranks #1382 out of 1418 companies for FCF Yield %. This places FibroBiologics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on FibroBiologics and its competitors. FibroBiologics's current FCF Yield % is -364.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FibroBiologics stock overvalued right now?
FibroBiologics (FBLG) has a current FCF Yield % of -364.82. The current FCF Yield % is -364.82. FibroBiologics' overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For FibroBiologics (FBLG), the current FCF Yield % is -364.82 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
13GF Score
Get the complete analysis for FBLG
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FBLG has been successfully added to your 
